SCHEMBL7678801

SCHEMBL7678801

CC(C)N(C(C)C)C(C)CC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10700267 0.79 CHRNB2 (0.31) —
SCHEMBL7525152 0.74 — —
SCHEMBL7670437 0.74 TSHR (0.38) —
SCHEMBL7672943 0.72 ALDH1A1 (0.30) —
SCHEMBL7670300 0.70 ALDH1A1 (0.33) —
SCHEMBL10768568 0.69 — —
SCHEMBL7672398 0.69 — —
SCHEMBL7677853 0.69 CA12 (0.30) —
SCHEMBL7672862 0.67 FDPS (0.37) —
SCHEMBL19741477 0.65 ALDH1A1 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104557561-A Method for preparing N1,N1-diisoprylamino ethylamine or salts of N1,N1-diisoprylamino ethylamine BEIJING YUEKANGKECHUANG MEDICAL TECHNOLOGY CO LTD 2015-04-29 — — CN claimed
US-6380197-B1 FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES AVENTIS PHARMA S. A. (FR) 2002-04-30 — — US claimed
CN-104557561-B A kind of preparation method of N1, N1-diisopropyl ethylenediamine or its salt 北京悦康科创医药科技有限公司 2016-07-06 — — CN disclosed
CN-104557561-B A kind of preparation method of N1, N1-diisopropyl ethylenediamine or its salt 北京悦康科创医药科技有限公司 2016-07-06 — — CN disclosed
CN-104557561-A Method for preparing N1,N1-diisoprylamino ethylamine or salts of N1,N1-diisoprylamino ethylamine BEIJING YUEKANGKECHUANG MEDICAL TECHNOLOGY CO LTD 2015-04-29 — — CN disclosed
US-6380197-B1 FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES AVENTIS PHARMA S. A. (FR) 2002-04-30 — — US disclosed
Send feedback